
Breathing through barriers: Lived experience, innovation, and the future of Alpha-1 care
Newsletters and Deep Dive digital magazine
At BIO 2025 in Boston today, pharma and biotech leaders discussed the current state of AI in the drug development life cycle.
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Developments in the oncology space in 2024 brought hope to both industry and patients.
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
Improving Global Access to Life-Changing Therapeutics...